112 related articles for article (PubMed ID: 21346352)
1. Efflux pump overexpression in conjunction with alternation of outer membrane protein may induce Acinetobacter baumannii resistant to imipenem.
Luo L; Jiang X; Wu Q; Wei L; Li J; Ying C
Chemotherapy; 2011; 57(1):77-84. PubMed ID: 21346352
[TBL] [Abstract][Full Text] [Related]
2. Differential susceptibility to carbapenems due to the AdeABC efflux pump among nosocomial outbreak isolates of Acinetobacter baumannii in a Chinese hospital.
Huang L; Sun L; Xu G; Xia T
Diagn Microbiol Infect Dis; 2008 Nov; 62(3):326-32. PubMed ID: 18687557
[TBL] [Abstract][Full Text] [Related]
3. Quantitative proteomic analysis of cell wall and plasma membrane fractions from multidrug-resistant Acinetobacter baumannii.
Yun SH; Choi CW; Kwon SO; Park GW; Cho K; Kwon KH; Kim JY; Yoo JS; Lee JC; Choi JS; Kim S; Kim SI
J Proteome Res; 2011 Feb; 10(2):459-69. PubMed ID: 21053951
[TBL] [Abstract][Full Text] [Related]
4. Study of the correlation of imipenem resistance with efflux pumps AdeABC, AdeIJK, AdeDE and AbeM in clinical isolates of Acinetobacter baumannii.
Hou PF; Chen XY; Yan GF; Wang YP; Ying CM
Chemotherapy; 2012; 58(2):152-8. PubMed ID: 22614896
[TBL] [Abstract][Full Text] [Related]
5. Outbreak of multiple clones of imipenem-resistant Acinetobacter baumannii isolates expressing OXA-58 carbapenemase in an intensive care unit.
Pournaras S; Markogiannakis A; Ikonomidis A; Kondyli L; Bethimouti K; Maniatis AN; Legakis NJ; Tsakris A
J Antimicrob Chemother; 2006 Mar; 57(3):557-61. PubMed ID: 16431857
[TBL] [Abstract][Full Text] [Related]
6. Outbreaks of imipenem-resistant Acinetobacter baumannii producing carbapenemases in Korea.
Jeong SH; Bae IK; Park KO; An YJ; Sohn SG; Jang SJ; Sung KH; Yang KS; Lee K; Young D; Lee SH
J Microbiol; 2006 Aug; 44(4):423-31. PubMed ID: 16953178
[TBL] [Abstract][Full Text] [Related]
7. Mechanisms of resistance to ciprofloxacin, ampicillin/sulbactam and imipenem in Acinetobacter baumannii clinical isolates in Taiwan.
Chiu CH; Lee HY; Tseng LY; Chen CL; Chia JH; Su LH; Liu SY
Int J Antimicrob Agents; 2010 Apr; 35(4):382-6. PubMed ID: 20138741
[TBL] [Abstract][Full Text] [Related]
8. CarO, an Acinetobacter baumannii outer membrane protein involved in carbapenem resistance, is essential for L-ornithine uptake.
Mussi MA; Relling VM; Limansky AS; Viale AM
FEBS Lett; 2007 Dec; 581(29):5573-8. PubMed ID: 17997983
[TBL] [Abstract][Full Text] [Related]
9. Differences in phenotypic and genotypic characteristics among imipenem-non-susceptible Acinetobacter isolates belonging to different genomic species in Taiwan.
Lee YT; Huang LY; Chiang DH; Chen CP; Chen TL; Wang FD; Fung CP; Siu LK; Cho WL
Int J Antimicrob Agents; 2009 Dec; 34(6):580-4. PubMed ID: 19733035
[TBL] [Abstract][Full Text] [Related]
10. bla(OXA-51)-type beta-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii.
Merkier AK; Centrón D
Int J Antimicrob Agents; 2006 Aug; 28(2):110-3. PubMed ID: 16844350
[TBL] [Abstract][Full Text] [Related]
11. [Multi-drug efflux pumps and antibiotic resistance in Acinetobacter baumannii].
Opazo AC; Mella SM; Domínguez MY; Bello HT; González GR
Rev Chilena Infectol; 2009 Dec; 26(6):499-503. PubMed ID: 20098782
[TBL] [Abstract][Full Text] [Related]
12. Structure-function relationships of CarO, the carbapenem resistance-associated outer membrane protein of Acinetobacter baumannii.
Catel-Ferreira M; Coadou G; Molle V; Mugnier P; Nordmann P; Siroy A; Jouenne T; Dé E
J Antimicrob Chemother; 2011 Sep; 66(9):2053-6. PubMed ID: 21705362
[TBL] [Abstract][Full Text] [Related]
13. Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina.
Brown S; Young HK; Amyes SG
Clin Microbiol Infect; 2005 Jan; 11(1):15-23. PubMed ID: 15649299
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and spread of integron-IS26 in imipenem-resistant Acinetobacter baumannii clinical isolates in South Korea.
Jeoung OY; Jang SJ; Li XM; Park G; Yong DE; Kang JO; Koo SH; Kim WY; Kim EC; Park YJ; Song WK; Shin JH; Ahn JY; Uh Y; Lee KW; Lee SH; Lee WG; Lee HS; Choi TY; Cho JH; Jeong SH; Hong SG; Lee J; Kim DM; Chang CL; Shin SH; Moon DS; Park YJ
Int J Antimicrob Agents; 2009 Dec; 34(6):612-4. PubMed ID: 19735991
[No Abstract] [Full Text] [Related]
15. Activity of the efflux pump inhibitor phenylalanine-arginine β-naphthylamide against the AdeFGH pump of Acinetobacter baumannii.
Cortez-Cordova J; Kumar A
Int J Antimicrob Agents; 2011 May; 37(5):420-4. PubMed ID: 21377839
[TBL] [Abstract][Full Text] [Related]
16. Synergic in-vitro activity of imipenem and sulbactam against Acinetobacter baumannii.
Choi JY; Park YS; Cho CH; Park YS; Shin SY; Song YG; Yong D; Lee K; Kim JM
Clin Microbiol Infect; 2004 Dec; 10(12):1098-101. PubMed ID: 15606639
[TBL] [Abstract][Full Text] [Related]
17. [Role of the AdeABC efflux pump in carbapenems resistance of clinical isolates of Acinetobacter baumannii].
Ma Z; Cai SX; Tong WC; Ruan SC; Wang H
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Aug; 31(8):1378-81. PubMed ID: 21868328
[TBL] [Abstract][Full Text] [Related]
18. Identification of an OprD homologue in Acinetobacter baumannii.
Dupont M; Pagès JM; Lafitte D; Siroy A; Bollet C
J Proteome Res; 2005; 4(6):2386-90. PubMed ID: 16335991
[TBL] [Abstract][Full Text] [Related]
19. [Study on carbapenemase and 16S rRNA methylase of imipenem-resistant Acinetobacter baumannii].
Zhou H; Du XX; Yang Q; Zhou JY; Yu YS; Li LJ
Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Mar; 30(3):269-72. PubMed ID: 19642384
[TBL] [Abstract][Full Text] [Related]
20. [Prevalence of Acinetobacter baumannii and Pseudomonas aeruginosa isolates resistant to imipenem by production of metallo-beta-lactamase].
Ait El Kadi M; Aghrouch M; Seffar M; El harti J; Bouklouze A; Cherrah Y; Souly K; Zouhdi M
Med Mal Infect; 2006 Jul; 36(7):386-9. PubMed ID: 16842953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
